Skip to content
sellModerate cluster of 4

Shoshana Shendelman sold $267k of APLT

President and CEO at Applied Therapeutics, Inc.. 61,795 shares at an average of $4.32, traded Jun 6, 2024, filed Jun 10, 2024.

Warning score
53
Value
$267k
61,795 shares
Holdings after
3,756,019
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $267k at market
    +13
  • Share of holdings sold
    Sold 1.6% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000950170-24-071333, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 6, 2024SOpen-market sale
Common Stock
-61,795$4.32$267k3,756,019Jun 10, 2024

Related signals

Other insiders at Applied Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
25Weak
APLTsell
Applied Therapeutics, Inc.
Stacy J. Kanter
director
$4,816
43,000 shares
-40%
30Weak
APLTsell 3
Applied Therapeutics, Inc.
Constantine Chinoporos
See Remarks
$197
447 shares
-0%
30Weak
APLTsell 3
Applied Therapeutics, Inc.
Leslie D. Funtleyder
See Remarks
$6,381
14,502 shares
-4%
30Weak
APLTsell 3
Applied Therapeutics, Inc.
Riccardo Perfetti
Chief Medical Officer
$4,561
10,366 shares
-1%
30Weak
APLTsell 3
Applied Therapeutics, Inc.
Constantine Chinoporos
See Remarks
$17k
28,117 shares
-9%
37Weak
APLTsell 3
Applied Therapeutics, Inc.
Riccardo Perfetti
Chief Medical Officer
$53k
86,078 shares
-9%
30Weak
APLTsell 3
Applied Therapeutics, Inc.
Leslie D. Funtleyder
See Remarks
$14k
22,950 shares
-5%
45Moderate
APLTsell 4
Applied Therapeutics, Inc.
Leslie D. Funtleyder
Chief Financial Officer
$73k
16,980 shares
-6%
40Moderate
APLTsell 4
Applied Therapeutics, Inc.
Riccardo Perfetti
Chief Medical Officer
$95k
22,003 shares
-2%
52Moderate
APLTsell 4
Applied Therapeutics, Inc.
Alexandria Real Estate Equities, Inc.
owner
$1.3M
300,000 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Shoshana Shendelman sold $267k of APLT | InsiderTell